Business Today
Loading...
COVID-19 vaccination: 23 elderly people dead after Pfizer shot in Norway

Norway COVID-19 immunisation: The Norwegian Institute of Public Health has cautioned against vaccinating elderly people above 80 years of age saying those with a short life span may not benefit much from the jab

COVID-19 vaccination: 23 elderly people dead after Pfizer shot in Norway

COVID-19 vaccination in Norway: Besides the 23 deaths, several people have fallen ill due to the Pfizer-BioNTech coronavirus vaccine

In a worrying development, 23 elderly people died within a short time of receiving their first coronavirus vaccine shots in Norway. However, there is no confirmation yet if there is direct correlation between the Pfizer-BioNTech COVID-19 jab and these deaths.

Although a direct correlation between the Pfizer jab and these deaths is yet to be established, experts have said that 13 out of 23 people who died showed common side effects of mRNA vaccines such as diarrhea, nausea and fever.

The Norwegian Institute of Public Health has cautioned against vaccinating elderly people above 80 years of age saying those with a short life span may not benefit much from the jab. The Norwegian regulator further told Bloomberg, "For those with the most severe frailty, even relatively mild vaccine side effects can have serious consequences."

Pfizer and BioNTech are working with the Norwegian authorities to investigate the deaths in Norway. According to Pfizer, the regulator discovered "the number of incidents so far is not alarming and in line with expectations".

Experts are of the strong opinion that doctors need to exercise strong caution in vaccinating people in the wake of deaths of 23 elderly people. The Norwegian Medicines Agency said in a recent report that 21 women and 8 men reported side effects. Apart from the 23 deaths, nine people have reported serious side effects without fatal outcomes such as allergic reactions, strong discomfort and severe fever. Seven people reported less serious side effects such as severe pain at the injection site.

Meanwhile, Norway had administered at least one dose of the Pfizer or Moderna coronavirus vaccines to approximately 33,000 people by end of December.

Also read: Pfizer must conduct local study for vaccine approval: VK Paul

Also read: Cyber attacks can plunge India's COVID vaccination drive into pandemonium: experts

Get latest news & live updates on the go on your phone with our News App. Download The Business Today news app on your device
More from BIZ WRAP